European Respiratory ReviewCell BiologyPeer-reviewed journal article
Artificial Intelligence-enabled Histological Analysis in Preclinical Respiratory Disease Models: A Scoping Review
Eva Kuhar, Junsoo ParkiD, Forough JahandidehiD, Majid KomeiliiD, Ahmed Sadeknury, Navneet Kang, Prarthna Karunamurthy, Mohammad Reza ZareiiD, Amir Ebrahimi, Sean E. GilliD, Patricia C. LiawiD, Dean A. FergussoniD, Duncan John StewartiD, Arvind Singh MeriD, Manoj Mathew LaluiD
- Citations
- 1
- FWCI
- 0.97
- Field percentile
- top 29%
Abstract
Histological analysis is a cornerstone of preclinical respiratory disease research, enabling assessment of pathology, therapeutic effects, and mechanisms. However, conventional approaches rely on manual scoring, which is subjective, time-consuming, and difficult to scale due to low throughput and inter-observer variability. Artificial intelligence (AI), particularly deep learning, offers potential to automate histology workflows, but its use and evaluation in preclinical respiratory models have not been synthesized. We conducted a scoping review following Joanna Briggs Institute guidelines, searching MEDLINE and Embase (inception-January 2025) for preclinical studies using AI to analyze histology in respiratory disease models. Screening, full-text review, and data extraction were performed in duplicate. Of 6271 studies screened, 29 met inclusion criteria. Most used murine models (76%) and investigated lung cancer (28%), pulmonary fibrosis (24%), or tuberculosis (17%). Hematoxylin and eosin was the most common stain (48%), with others targeting collagen or immune markers. AI tasks included image classification (n=20), segmentation (n=10), and object detection (n=4), predominantly using convolutional neural networks (69%). Preprocessing methods (e.g., stain normalization) were common, but annotation and training practices were inconsistently reported. Performance was generally high (accuracy [≥]90%; 7 studies) though validation metrics varied, and external validation was absent. Most studies used "black box" models, with minimal application of explainability techniques. Reproducibility measures, such as sharing datasets or code were rarely reported. AI tools are poised to transform histological analysis in preclinical respiratory research. By addressing gaps in validation, transparency, and standardization, the field can harness these technologies to deliver robust, efficient, and scalable workflows. Registration: Open Science Framework https://doi.org/10.17605/OSF.IO/NM94E
- organism: mouse
- assay: imaging
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- approach: benchmark study
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Improving Data Quality, Model Transparency and Performance in Lung Histopathology with Explainable AI
Salma Kazemi Rashed, Mikael Nilsson, Sonja Aits·bioRxiv·Sep 21, 2026
- Benchmarking artificial intelligence methods for end-to-end computational pathology
Narmin Ghaffari Laleh, Hannah Sophie Muti, … Jakob Nikolas Kather·bioRxiv·Aug 9, 2021
- ComPRePS: Unlocking Scalable AI Analysis for Computational Renal Pathology
A. S. Paul, L. A. Rodrigues, … P. Sarder·bioRxiv·Mar 21, 2024
- Deep Learning-based Modeling for Preclinical Drug Safety Assessment
Guillaume Jaume, Simone de Brot, … Faisal Mahmood·bioRxiv·Jul 20, 2024
- Deep learning for rapid and reproducible histology scoring of lung injury in a porcine model
Iran A. N. Silva, Salma Kazemi Rashed, … Darcy Elizabeth Wagner·bioRxiv·May 12, 2023
- Impact of tissue staining and scanner variation on the performance of pathology foundation models: a study of sarcomas and their mimics
Binghao Chai, Jianan Chen, … Adrienne Margaret Flanagan·The Journal of Pathology Clinical ResearchPeer-reviewed·Feb 24, 2026